AzTrials
AzTrials

Self-etchNCT03798184

Clinical Performance of Prime&Bond Active in Self-etch or Selective-etch Mode With or Without Bioglass

A study testing Non-carious cervical lesion restoration in people with Self-etch and Selective-etch, run by University of Valencia at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Composite restoration of non-carious cervical lesions has always been a challenge for the clinician, considering that the most frequent cause of failure is retention loss. Adhesion of composite restoration may be obtained by following four different etching techniques: total-etch in three steps, total-etch in two… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Self-etch, Selective-etch, Bioactive Glass
What is being tested?
Non-carious cervical lesion restoration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
228 participants
Where
1 siteSpain
Study dates
19 Nov 2018to Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients ≥ 18 years without systemic disease.
  • Presence of a non-carious cervical lesion with a minimum of 1.5 mm in depth and extent to dentin.
  • Non-carious cervical lesions in premolars and molars.

Who cannot join

  • Presence of rampant caries or advanced periodontal disease.
  • Consumption of > 2 cigarette pack/ day.
  • Presence of severe xerostomia or bruxism.
  • Methacrylate allergy.
  • Pregnancy.
  • Teeth with pulpal and/or periapical pathology, and endodontically treated teeth are excluded from the study.
  • Teeth with previous pulp capping or previous class V restorations will also be excluded.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Valencia

    Valencia

Other trials in Spain

About this study

Official title: Randomized Blind Clinical Trial, Four-armed Parallel of Clinical Performance of Prime&Bond Active in Self-etch or Selective-etch With or Without Bioglass

Composite restoration of non-carious cervical lesions has always been a challenge for the clinician, considering that the most frequent cause of failure is retention loss.

Adhesion of composite restoration may be obtained by following four different etching techniques: total-etch in three steps, total-etch in two steps, self-etch in two steps, and self-etch in one step. Nowadays the tendency is to simplify the adhesive classic protocols. With the introduction of universal adhesives such as Prime\&Bond Active (Dentsply Sirona) it is possible to obtain a total-etch pattern (enamel and dentine) without the classic etching technique with orthophosphoric acid.

Read more

On the other hand, there has been an increase in the awareness of the importance of remaining dental tissue preservation, avoiding preparation of a cavity. This is why it is now preferable to use bioactive glass in order to increase micromechanical retention on the dental surface, instead of the classical approach of preparing the surface with burs.

To date, there are no studies evaluating the clinical performance of the universal adhesive Prime\&Bond Active on direct resin composite restoration of non-carious cervical lesions neither in a selective-etch mode (enamel etching) or a self-etch mode (no etching) or using sandblasting with bioactive glass. Therefore, the main objective of the study is to evaluate the retention rate of composite restorations using Prime\&Bond Active and a previous sandblasted surface with bioglass in a three-year follow-up, as well as the presence of marginal discoloration, marginal integrity and marginal caries.

Read the detailed description

The protocol to be followed in the study is as follows:

  1. Obtention of a written informed consent of all participants.
  2. Complete medical and dental clinical record.
  3. Administration of anesthesia and absolute rubber dam isolation.
  4. Cavity cleaning with a prophylactic brush and rubber cup with pumice.
  5. Randomly assigning each non-carious cervical lesion to one of the four experimental groups: 5.1. Selective enamel etching and surface roughening with bioglass 5.2. Selective enamel etching without surface roughening. 5.3. Self-etch and surface roughening with bioglass. 5.4. Self-etch without surface roughening.
  6. In experimental groups which need surface roughening (group 5.1 and 5.3), sandblasting with bioactive glass will be used in enamel.
  7. In experimental groups with selective enamel etch (5.1 and 5.2), 37 % orthophosphoric acid is applied for 15 seconds in enamel, followed by profuse washing with air/water spray for ten seconds and dried using air for 10 seconds without desiccating dentin. In groups 5.3 and 5.4 this step is omitted.
  8. Application of universal adhesive Prime\&Bond Active on enamel and dentin for 20 seconds. Subsequently, evaporation of the solvent is realized by applying air for 5 seconds and then light curing for 20 seconds.
  9. Application of a "bulk fill" composite resin and light curing, following manufacturer's instructions.
  10. Finishing and polishing of the restoration.
  11. Monitoring and follow up: visits will be performed at six months, one year, two years and three years. In each evaluation, two independent clinicians who do not participate in the clinical procedures will evaluate each direct composite restoration according to USPHS criteria (Modified United States Public Health Service).

The primary objective is to evaluate the retention of the restoration. The secondary objectives are to evaluate marginal discoloration, marginal integrity and marginal caries.

Being tested
Non-carious cervical lesion restoration
Keywords
Prime&Bond Active, Bioactive glass, non-carious cervical lesion, direct resin composite

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-carious cervical lesion restorationProcedure or surgery

    Restoration of non-carious cervical lesions with Prime\&Bond Active in self-etch or selective-etch mode with or without bioglass

Study groups in NCT03798184
Study groupRoleWhat they receive
Selective-etch with bioglass surface rougheningExperimentalNot described
Receives: Procedure: Non-carious cervical lesion restoration
Selective-etch without bioglass surface rougheningActive comparatorNot described
Receives: Procedure: Non-carious cervical lesion restoration
Self-etch with bioglass surface rougheningExperimentalNot described
Receives: Procedure: Non-carious cervical lesion restoration
Self-etch without bioglass surface rougheningActive comparatorNot described
Receives: Procedure: Non-carious cervical lesion restoration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention rate

    Presence of resin composite restorations of non-carious cervical lesions at the three-year follow-up examination.

    Measured: Three years

Secondary outcomes (3)
  1. Marginal discoloration

    Presence of marginal staining between the restoration and tooth will be evaluated following USPHS criteria (Modified United States Public Health Service)

    Measured: Three years

  2. Marginal integrity

    The quality of the interface between restoration and tooth will be evaluated following USPHS criteria (Modified United States Public Health Service)

    Measured: Three years

  3. Marginal caries

    The presence of clinical diagnosis of caries will be evaluated following USPHS criteria (Modified United States Public Health Service)

    Measured: Three years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2019
  2. Study start19 Nov 2018
  3. Primary completionNov 2019 (estimated)
  4. Study completionNov 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
228 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03798184
Sponsor's protocol ID
2/2018
Status last verified
Jan 2019
First submitted
18 Nov 2018
Last updated
9 Jan 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Non-carious cervical lesion restoration in people with Self-etch and Selective-etch, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention rate (time frame: Three years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in